-+undefined NaN%
-+undefined NaN%
-+undefined NaN%

UBS Downgrades Cano Health to Neutral From Buy, Adjusts Price Target to $1.25 From $12

UBS Downgrades Cano Health to Neutral From Buy, Adjusts Price Target to $1.25 From $12

MT Newswires · 01/06/2023 05:00